DFDA

Mebendazole

Treatment for Cystic Echinococcosis

Typical Dosage: 40-50 mg/kg/day in 3 divided doses

Effectiveness
45%
Safety Score
70%
Clinical Trials
20
Participants
1.5K

Comparative Safety Scale(Higher is safer)

Cyanideâ˜ ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
40-50 mg/kg/day in 3 divided doses
Time to Effect
3-6 months
Treatment Duration
3-6 months or longer, continuous treatment
Evidence Quality
MODERATE
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,400
Monitoring:$1,000
Side Effect Mgmt:$200
Total Annual:$3,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
Outcome-Based Costs
Cost per Responder
$8,000
Cost per Remission
$24,000
Comparison vs Albendazole
Cost Difference
$-2,000/year
Less expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Prescription Access Economics
Risk Assessment
Requires Monitoring
Yes
Needs lab work/checkups
Mebendazole Outcomes

for Cystic Echinococcosis

Efficacy Outcomes
Overall Effectiveness
+45%
Response Rate
+45%
Remission Rate
+15%
Common Side Effects
Gastrointestinal upset
+10%
Headache
+7%
Abdominal pain
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov